Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trialYuzhou Zhao, Ying Liu, Shuning Xu et al.|Clinical and Translational Medicine|2024Cited by 22
Clinicopathological features and prognoses in younger and older patients with mismatch repair defects colorectal cancer: a retrospective comparative cohort studyJiachen Zhang, Yuzhou Zhao, Sen Li et al.|Journal of Gastrointestinal Oncology|2024Cited by 4
Efficacy and safety of camrelizumab combined with FOLFOX as neoadjuvant therapy for patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy.Yuzhou Zhao, Xijie Zhang, Guangsen Han et al.|Journal of Clinical Oncology|2020Cited by 2
Postoperative superior anastomotic leakage classification and treatment strategy for postoperative esophagogastric junction cancerJunli Zhang, Yuzhou Zhao, Changzheng Li et al.|Journal of Gastrointestinal Oncology|2024Cited by 1
Selection of Digestive Tract Reconstruction After Partial Gastric Sparing Surgery in Patients With Adenocarcinoma of the Esophagogastric Junction of cT2-T3 StageJunli Zhang, Yuzhou Zhao, Xijie Zhang et al.|Frontiers in Surgery|2022Cited by 0